2025 Annual Meeting | PL4 - Contemporary Clinical Issues Plenary Session
Program Materials Program Evaluations
| 09:15 AM - 09:25 AM PDT | Speaker |
Presenter: Association Between Non-English Language Preference, Delirium Occurrence, and Inpatient Outcomes
Mary C. Zuniga, MD |
| 09:25 AM - 09:35 AM PDT | Speaker |
Discussant: Association Between Non-English Language Preference, Delirium Occurrence, and Inpatient Outcomes
Nicole Gonzales, MD |
| 09:35 AM - 09:45 AM PDT | Speaker |
Presenter: Autoimmune Encephalitis Is the Most Common Treatment-Responsive Cause of Rapidly Progressive Dementia: A Large Dutch Prospective Cohort Study
Robin van Steenhoven, MD |
| 09:45 AM - 09:55 AM PDT | Speaker |
Discussant: Autoimmune Encephalitis Is the Most Common Treatment-Responsive Cause of Rapidly Progressive Dementia: A Large Dutch Prospective Cohort Study
Stacey Clardy, MD, PhD, FAAN |
| 09:55 AM - 10:05 AM PDT | Speaker |
Presenter: Placental and Breastmilk Transfer of Ocrelizumab from Women with Multiple Sclerosis to Infants and the Potential Impact on B-Cell Levels: Primary Analysis of the Prospective, Multicenter, Open-label, Phase IV Studies MINORE and SOPRANINO
Riley Bove, MD, FAAN |
| 10:05 AM - 10:15 AM PDT | Speaker |
Discussant: Placental and Breastmilk Transfer of Ocrelizumab from Women with Multiple Sclerosis to Infants and the Potential Impact on B-Cell Levels: Primary Analysis of the Prospective, Multicenter, Open-label, Phase IV Studies MINORE and SOPRANINO
Sandra Vukusic, MD |
| 10:15 AM - 10:25 AM PDT | Speaker |
Presenter: Impact of Rurality on Treatment and Survival in Patients with Brain Metastases
Thomas Khodadad |
| 10:25 AM - 10:35 AM PDT | Speaker |
Discussant: Impact of Rurality on Treatment and Survival in Patients with Brain Metastases
Antonio M. Omuro, MD, FAAN |
| 10:35 AM - 10:45 AM PDT | Speaker |
Presenter: Obstructive Sleep Apnea is a Risk Factor for Parkinson’s Disease and CPAP Mitigates Risk of PD: An EHR-based Cohort Study in Military Veterans
Isabella Montano |
| 10:45 AM - 10:55 AM PDT | Speaker |
Discussant: Obstructive Sleep Apnea is a Risk Factor for Parkinson’s Disease and CPAP Mitigates Risk of PD: An EHR-based Cohort Study in Military Veterans
Roneil Malkani, MD |
| Antonio M. Omuro, MD, FAAN | Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Telix. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curevac. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Arcus Biosciences. The institution of Dr. Omuro has received research support from Denovo Biopharma. The institution of Dr. Omuro has received research support from Ono Pharmaceutical. The institution of Dr. Omuro has received research support from Servier. The institution of Dr. Omuro has received research support from Nanopharmaceuticals. The institution of Dr. Omuro has received research support from Denovo. |
| Sandra Vukusic, MD | The institution of Dr. Vukusic has received research support from Biogen. The institution of Dr. Vukusic has received research support from Janssen. The institution of Dr. Vukusic has received research support from Merck. The institution of Dr. Vukusic has received research support from Novartis. The institution of Dr. Vukusic has received research support from Roche. |
| Nicole Gonzales, MD | The institution of Dr. Gonzales has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. |
| Stacey Clardy, MD, PhD, FAAN | Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed. |
| Fernando D. Testai, MD, PhD, FAAN | Dr. Testai has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Testai has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Livingston, Barger, Brandt & Schroeder, L.L.P.. Dr. Testai has received publishing royalties from a publication relating to health care. |
| Roneil Malkani, MD | The institution of Dr. Malkani has received research support from NIH. The institution of Dr. Malkani has received research support from Northwestern University. Dr. Malkani has received personal compensation in the range of $500-$4,999 for serving as a Author with 好色先生. Dr. Malkani has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with Weston Family Foundation. Dr. Malkani has received personal compensation in the range of $500-$4,999 for serving as a Consultant with American Academy of Sleep Medicine. Dr. Malkani has a non-compensated relationship as a Committee Member with American Academy of Sleep Medicine that is relevant to AAN interests or activities. Dr. Malkani has a non-compensated relationship as a Board Member with Illinois Sleep Society that is relevant to AAN interests or activities. Dr. Malkani has a non-compensated relationship as a Review editor on editorial board with Frontiers that is relevant to AAN interests or activities. |
| Riley Bove, MD, FAAN | Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeurologyLive. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Roche Genentech. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Eli Lilly. |
| Mary C. Zuniga, MD | Dr. Zuniga has nothing to disclose. |
| Robin van Steenhoven, MD | Mr. van Steenhoven has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Imeedu . The institution of Mr. van Steenhoven has received research support from Autoimmune Encephalitis Alliance . The institution of Mr. van Steenhoven has received research support from Dutch Alzheimer's foundation. |
| Thomas Khodadad | Mr. Khodadad has nothing to disclose. |
| Isabella Montano | Ms. Montano has nothing to disclose. |